Glyxambi (Empagliflozin / Linagliptin)

Prescription Glyxambi is a combination of empagliflozin (Jardiance) and linagliptin (Tradjenta) to treat adults with type 2 diabetes along with know CV (cardiovascular) disease.  Glyxambi is an appropriate medicine for people would can otherwise take both Jardiance and Tradjenta.  Glyxambi is taken along with a good diet and exercise regime.

Glyxambi works multiple ways to lower blood sugar, improve A1C levels, and even may reduce risk of death by cardiovascular disease.  Although, Glyxambi has not been studied in respect to cardiovascular death, empagliflozin, part of Glyxambi, has shown to reduce cardiovascular death.

Glyxambi works by increasing your own insulin production, reducing your own sugar production, and causes more sugar to pass through your urine.  

In clinical studies, 58% of people taking Glyxambi lowered their A1C levels below 7.0.  Also, fasting blood sugar levels were reduced by an average 33 points and an average weight loss of 3% was attained.

Glyxambi is taken once daily in the morning and is the first of this type of combination medicine.

In 2019, when comparing Glyxambi cost to USA Glyxambi coupon price, InsulinHub was found to offer a discount of approximately 60% in Glyxambi savings.

Buy Glyxambi from InsulinHub.com for the best Glyxambi cost.

This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees celsius, and contact the pharmacy immediately.